Next Article in Journal
Bovine Lactoferrin Modulates Dendritic Cell Differentiation and Function
Next Article in Special Issue
VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues
Previous Article in Journal
Dietary Intake and Food Sources of Niacin, Riboflavin, Thiamin and Vitamin B6 in a Representative Sample of the Spanish Population. The ANIBES Study
Previous Article in Special Issue
A Novel Biomimetic Tool for Assessing Vitamin K Status Based on Molecularly Imprinted Polymers
Open AccessFeature PaperReview

Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity

1
Institute of Health and Sport, Victoria University, Melbourne, VIC 8011, Australia
2
Department of Physiology, Bosch Institute for Medical Research, University of Sydney, Sydney, NSW 2006, Australia
3
Australian Institute for Musculoskeletal Science, Department of Medicine, Western Health, Melbourne Medical School, University of Melbourne, Melbourne, VIC 3021, Australia
4
The Medical School, University of Western Australia, Perth, WA 6009, Australia
5
Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, WA 6150, Australia
*
Authors to whom correspondence should be addressed.
Nutrients 2018, 10(7), 847; https://doi.org/10.3390/nu10070847
Received: 7 June 2018 / Revised: 22 June 2018 / Accepted: 25 June 2018 / Published: 29 June 2018
(This article belongs to the Special Issue Vitamin K in Human Health and Disease)
Recent advances have indicated that osteocalcin, and in particular its undercarboxylated form (ucOC), is not only a nutritional biomarker reflective of vitamin K status and an indicator of bone health but also an active hormone that mediates glucose metabolism in experimental studies. This work has been supported by the putative identification of G protein-coupled receptor, class C, group 6, member A (GPRC6A) as a cell surface receptor for ucOC. Of note, ucOC has been associated with diabetes and with cardiovascular risk in epidemiological studies, consistent with a pathophysiological role for ucOC in vivo. Limitations of existing knowledge include uncertainty regarding the underlying mechanisms by which ucOC interacts with GPRC6A to modulate metabolic and cardiovascular outcomes, technical issues with commonly used assays for ucOC in serum, and a paucity of clinical trials to prove causation and illuminate the scope for novel health interventions. A key emerging area of research is the role of ucOC in relation to expression of GPRC6A in muscle, and whether exercise interventions may modulate metabolic outcomes favorably in part via ucOC. Further research is warranted to clarify potential direct and indirect roles for ucOC in human health and cardiometabolic diseases. View Full-Text
Keywords: osteocalcin; undercarboxylated osteocalcin; GPRC6A; insulin resistance; diabetes; cardiovascular disease; bone; muscle osteocalcin; undercarboxylated osteocalcin; GPRC6A; insulin resistance; diabetes; cardiovascular disease; bone; muscle
MDPI and ACS Style

Lin, X.; Brennan-Speranza, T.C.; Levinger, I.; Yeap, B.B. Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity. Nutrients 2018, 10, 847.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop